Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 21, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Radiofrequency interstitial tumor ablation: dry electrode.

D Brooke Johnson1, Jeffrey A Cadeddu

  • 1Clinical Center for Minimally Invasive Urologic Cancer Treatment, Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.

Journal of Endourology
|November 19, 2003
PubMed
Summary

Dry-electrode radiofrequency ablation (RFA) offers a nephron-sparing option for small renal tumors. While RFA shows promise in creating targeted lesions, its long-term efficacy requires further evaluation through patient survival data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoscopy/New Technology.

The Journal of urology·2021
Same author

Laparoscopy/New Technology.

The Journal of urology·2020
Same author

Irreversible Electroporation for Renal Ablation Does Not Cause Significant Injury to Adjacent Ureter or Bowel in a Porcine Model.

Journal of endourology·2020
Same author

Laparoscopy/New Technology.

The Journal of urology·2020
Same author

Laparoscopy/New Technology.

The Journal of urology·2020
Same author

Re: Robot-Assisted Radical Prostatectomy in Patients with a History of Holmium Laser Enucleation of the Prostate: The Indiana University Experience.

The Journal of urology·2020

Area of Science:

  • Oncology
  • Medical Physics
  • Nephrology

Background:

  • The treatment paradigm for small renal tumors is shifting towards nephron-sparing techniques.
  • Dry-electrode radiofrequency ablation (RFA) is an emerging modality in this context.
  • RFA utilizes radiofrequency energy to generate heat, ablating tissue via native impedance.

Purpose of the Study:

  • To evaluate radiofrequency ablation (RFA) as a nephron-sparing treatment for small renal tumors.
  • To assess the feasibility and preliminary outcomes of RFA in renal tumor ablation.

Main Methods:

  • Application of RF energy using dry electrodes to target renal tumors.
  • Utilizing the native impedance of living tissue to create localized heat.
  • Review of animal studies and human clinical series data.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Experiment Videos

Last Updated: Jun 21, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Main Results:

  • RFA demonstrated the ability to create controlled, targeted, and reproducible lesions in animal studies and human series.
  • Most clinical studies reported promising initial results.
  • Some studies raise questions regarding the complete destruction of tumors by RFA.

Conclusions:

  • Radiofrequency ablation (RFA) is a potential nephron-sparing approach for small renal tumors.
  • Further long-term studies are necessary to determine the definitive efficacy of RFA, particularly patient survival rates.
  • The ultimate role of RFA in comparison to other therapeutic modalities for small renal tumors remains to be established.